We are happy to announce that the Norwegian family-owned investment company Ferd will come as a co-owner of Aidian together with Nordstjerna...
Viruses are major causes of upper respiratory tract infections (URTIs). Yet, antibiotics are commonly prescribed for URTIs. Even if, the flu...
We have updated our website with a new sustainability section. You can now find more information about sustainability at Aidian, our commitm...
Emerging evidence show that among patients with COVID-19, the risk of death of diabetes is 50% higher than those without diabetes, especiall...
Non-invasive point of care (POC) faecal immunochemical tests (FITs) aid in triaging both asymptomatic and symptomatic patients for colonosco...
The new re-designed QuikRead go workstation is now available! It is designed to ensure effortless testing with the QuikRead go -system and i...
A recent review article by Luan et. al aimed to highlight the current and most recent studies with regard to the clinical significance of C-...
On the 18th of February 2022 the Swedish investment company Nordstjernan signed the agreement to acquire Aidian Oy and it will be effective ...